Fas and the tumor necrosis factor receptor (TNFR)1 regulate the programmed cell death of lymphocytes. The death domain kinase, receptor interacting protein (rip), is recruited to the TNFR1 upon receptor activation. In vitro, rip−/− fibroblasts are sensitive to TNF-induced cell death due to an impaired nuclear factor κB response. Because rip−/− mice die at birth, we were unable to examine the effects of a targeted rip mutation on lymphocyte survival. To address the contribution of RIP to immune homeostasis, we examined lethally irradiated mice reconstituted with rip−/− hematopoietic precursors. We observed a decrease in rip−/− thymocytes and T cells in both wild-type C57BL/6 and recombination activating gene 1−/− irradiated hosts. In contrast, the B cell and myeloid lineages are unaffected by the absence of rip. Thus, the death domain kinase rip is required for T cell development. Unlike Fas-associated death domain, rip does not regulate T cell proliferation, as rip−/− T cells respond to polyclonal activators. However, rip-deficient mice contain few viable CD4+ and CD8+ thymocytes, and rip−/− thymocytes are sensitive to TNF-induced cell death. Surprisingly, the rip-associated thymocyte apoptosis was not rescued by the absence of TNFR1, but appears to be rescued by an absence of TNFR2. Taken together, this study implicates RIP and TNFR2 in thymocyte survival.
Skip Nav Destination
Article navigation
1 July 2002
Article Contents
Article|
July 01 2002
The Death Domain Kinase RIP Protects Thymocytes from Tumor Necrosis Factor Receptor Type 2–induced Cell Death
Nicole Cusson,
Nicole Cusson
Department of Molecular Genetics and Microbiology, Program in Immunology/Virology, University of Massachusetts Medical School, Worcester, MA 01605
Search for other works by this author on:
Sarah Oikemus,
Sarah Oikemus
Department of Molecular Genetics and Microbiology, Program in Immunology/Virology, University of Massachusetts Medical School, Worcester, MA 01605
Search for other works by this author on:
Elizabeth D. Kilpatrick,
Elizabeth D. Kilpatrick
Department of Molecular Genetics and Microbiology, Program in Immunology/Virology, University of Massachusetts Medical School, Worcester, MA 01605
Search for other works by this author on:
Leslie Cunningham,
Leslie Cunningham
Department of Molecular Genetics and Microbiology, Program in Immunology/Virology, University of Massachusetts Medical School, Worcester, MA 01605
Search for other works by this author on:
Michelle Kelliher
Michelle Kelliher
Department of Molecular Genetics and Microbiology, Program in Immunology/Virology, University of Massachusetts Medical School, Worcester, MA 01605
Search for other works by this author on:
Nicole Cusson
Department of Molecular Genetics and Microbiology, Program in Immunology/Virology, University of Massachusetts Medical School, Worcester, MA 01605
Sarah Oikemus
Department of Molecular Genetics and Microbiology, Program in Immunology/Virology, University of Massachusetts Medical School, Worcester, MA 01605
Elizabeth D. Kilpatrick
Department of Molecular Genetics and Microbiology, Program in Immunology/Virology, University of Massachusetts Medical School, Worcester, MA 01605
Leslie Cunningham
Department of Molecular Genetics and Microbiology, Program in Immunology/Virology, University of Massachusetts Medical School, Worcester, MA 01605
Michelle Kelliher
Department of Molecular Genetics and Microbiology, Program in Immunology/Virology, University of Massachusetts Medical School, Worcester, MA 01605
Address correspondence to Michelle Kelliher, University of Massachusetts Medical School, Two BioTech, 373 Plantation Street, Worcester, MA 01605. Phone: 508-856-8620; Fax: 508-856-8311; E-mail: [email protected]
N. Cusson and S. Oikemus contributed equally to this work.
*
Abbreviations used in this paper: CFSE, carboxyfluorescein diacetate succinimidyl ester; DN, double negative; DP, double positive; FADD, Fas-associated death domain; NF, nuclear factor; rip, receptor interacting protein; TRADD, TNFR1-associated death domain; TRAF2, TNFR-associated factor 2.
Received:
August 24 2001
Revision Received:
March 27 2002
Accepted:
May 06 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 196 (1): 15–26.
Article history
Received:
August 24 2001
Revision Received:
March 27 2002
Accepted:
May 06 2002
Citation
Nicole Cusson, Sarah Oikemus, Elizabeth D. Kilpatrick, Leslie Cunningham, Michelle Kelliher; The Death Domain Kinase RIP Protects Thymocytes from Tumor Necrosis Factor Receptor Type 2–induced Cell Death . J Exp Med 1 July 2002; 196 (1): 15–26. doi: https://doi.org/10.1084/jem.20011470
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement